US Edition#Navigating Change: Merit Medicals Leadership Shift Amidst Promising Innovations
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
#Navigating Change: Merit Medicals Leadership Shift Amidst Promising Innovations
In a pivotal moment for Merit Medical Systems, Inc. the company has announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. This transition comes at a critical juncture as the company contemplates its strategic direction amidst mixed financial performance and a significant regulatory achievement. Despite Wright's departure, Merit Medical has reported a commendable return on assets (ROA) of 5.11% for the third qua…
Merit Medical’s Wrapsody Receives FDA Approval - Endovascular Today
December 20, 2024—Merit Medical Systems, Inc. announced that the Wrapsody cell-impermeable endoprosthesis has received premarket approval from the FDA. The company stated that it can begin commercialization of the device in the United States in 2025. According to the company, the Wrapsody device is a flexible, self-expanding endoprosthesis indicated for use in hemodialysis patients for the treatment of stenosis or occlusion within the dialysis a…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
